Table 3. Prevalence of Hyperthyroidism in Patients Undergoing Treatment in 2015.

	Total			Men			Women
	Population	Events	Prevalencea	Population	Events	Prevalencea	Population	Events	Prevalencea
Total	51,834,660	143,321	2.76	25,933,249	46,453	1.79	25,901,411	96,868	3.74
Age group, yr
≤9	4,619,384	148	0.03	2,375,043	26	0.01	2,244,341	122	0.05
10–19	5,709,599	4,252	0.74	2,977,410	849	0.29	2,732,189	3,403	1.25
20–29	6,881,546	11,512	1.67	3,643,304	3,038	0.83	3,238,242	8,474	2.62
30–39	7,824,337	23,596	3.02	4,019,283	8,037	2.00	3,805,054	15,559	4.09
40–49	8,871,241	31,542	3.56	4,502,350	12,398	2.75	4,368,891	19,144	4.38
50–59	8,332,932	34,939	4.19	4,184,758	12,100	2.89	4,148,174	22,839	5.51
60–69	5,064,740	21,578	4.26	2,457,128	6,700	2.73	2,607,612	14,878	5.71
70–79	3,153,746	12,138	3.85	1,352,287	2,798	2.07	1,801,459	9,340	5.18
≥80	1,377,135	3,616	2.63	421,686	507	1.20	955,449	3,109	3.25

^aPrevalence was calculated by dividing the number of prevalent cases by the total population and presented per 1,000 population.